Literature DB >> 11948806

Immunohistological localization of the myelinating cell-specific receptor LP(A1).

Pascale Cervera1, Marilyn Tirard, Sonia Barron, Julien Allard, Suzanne Trottier, Joëlle Lacombe, Catherine Daumas-Duport, Pierre Sokoloff.   

Abstract

LP(A1) (also termed Edg-2 or VZG-1) is a G-protein-coupled receptor for lysophosphatidic acid and its gene transcripts have been found selectively expressed by mature myelin-producing cells. We have raised in rabbit a polyclonal antibody against a sequence unique to LP(A1) and common to rat, mouse, and human orthologues. In Western blots, LP(A1) immunoreactivity appeared as 44-53 kDa bands in extracts from recombinant RH7777 cells expressing LP(A1), mouse purified oligodendrocytes, or human white matter, but not from wild-type RH7777 cells or purified astrocytes. In glial cultures, LP(A1) immunoreactivity was restricted to oligodendrocytes, appeared at cell membrane and processes, colocalized with myelin basic protein, and appeared before myelin/oligodendrocyte glycoprotein. In slices of rat and human brains, LP(A1) immunoreactivity was found in myelinated tracts, as well as in oligodendrocyte somata and their myelinating fibers. Immunoreactivities of LP(A1) and myelin basic protein colocalized in the brain, but oligodendrocyte soma showed stronger signals for LP(A1) than myelinated fibers, whereas the reverse was true for myelin basic protein. These results strengthen the view that LP(A1) is involved in myelin formation or maintenance. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11948806     DOI: 10.1002/glia.10054

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  13 in total

1.  The basic secretagogue compound 48/80 activates G proteins indirectly via stimulation of phospholipase D-lysophosphatidic acid receptor axis and 5-HT1A receptors in rat brain sections.

Authors:  Ville A B Palomäki; Jarmo T Laitinen
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

2.  Lysophosphatidic acid can support the formation of membranous structures and an increase in MBP mRNA levels in differentiating oligodendrocytes.

Authors:  Luciana Nogaroli; Larra M Yuelling; Jameel Dennis; Karen Gorse; Shawn G Payne; Babette Fuss
Journal:  Neurochem Res       Date:  2008-07-02       Impact factor: 3.996

3.  Oncostatin M-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelination.

Authors:  Evelien Houben; Kris Janssens; Doryssa Hermans; Jennifer Vandooren; Chris Van den Haute; Melissa Schepers; Tim Vanmierlo; Ivo Lambrichts; Jack van Horssen; Veerle Baekelandt; Ghislain Opdenakker; Wia Baron; Bieke Broux; Helena Slaets; Niels Hellings
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-18       Impact factor: 11.205

4.  Lysophosphatidic acid (LPA) and its receptor, LPA1 , influence embryonic schwann cell migration, myelination, and cell-to-axon segregation.

Authors:  Brigitte Anliker; Ji Woong Choi; Mu-En Lin; Shannon E Gardell; Richard R Rivera; Grace Kennedy; Jerold Chun
Journal:  Glia       Date:  2013-09-24       Impact factor: 7.452

Review 5.  Lysophosphatidic Acid signaling in the nervous system.

Authors:  Yun C Yung; Nicole C Stoddard; Hope Mirendil; Jerold Chun
Journal:  Neuron       Date:  2015-02-18       Impact factor: 17.173

Review 6.  Lysophospholipids and their receptors in the central nervous system.

Authors:  Ji Woong Choi; Jerold Chun
Journal:  Biochim Biophys Acta       Date:  2012-07-31

Review 7.  Lysophosphatidic Acid Signalling in Nervous System Development and Function.

Authors:  Eric Birgbauer
Journal:  Neuromolecular Med       Date:  2020-11-05       Impact factor: 3.843

Review 8.  LPA receptor signaling: pharmacology, physiology, and pathophysiology.

Authors:  Yun C Yung; Nicole C Stoddard; Jerold Chun
Journal:  J Lipid Res       Date:  2014-03-18       Impact factor: 5.922

9.  Lipid phosphate phosphatase inhibitors locally amplify lysophosphatidic acid LPA1 receptor signalling in rat brain cryosections without affecting global LPA degradation.

Authors:  Niina Aaltonen; Marko Lehtonen; Katri Varonen; Gemma Arrufat Goterris; Jarmo T Laitinen
Journal:  BMC Pharmacol       Date:  2012-06-11

Review 10.  Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders.

Authors:  Emmanuelle Charrier; Sophie Reibel; Véronique Rogemond; Michèle Aguera; Nicole Thomasset; Jérôme Honnorat
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.